Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Androgen | 6 | 2019 | 1057 | 1.370 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2019 | 170 | 0.660 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2018 | 108 | 0.660 |
Why?
|
| Receptors, CXCR | 1 | 2018 | 52 | 0.650 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2018 | 109 | 0.640 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2019 | 441 | 0.600 |
Why?
|
| MicroRNAs | 3 | 2018 | 3731 | 0.600 |
Why?
|
| Phenylthiohydantoin | 1 | 2018 | 192 | 0.590 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2019 | 8425 | 0.560 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2010 | 462 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 2502 | 0.350 |
Why?
|
| Cell Line, Tumor | 9 | 2019 | 16665 | 0.330 |
Why?
|
| Wnt Proteins | 1 | 2013 | 721 | 0.330 |
Why?
|
| Androgens | 2 | 2013 | 1271 | 0.320 |
Why?
|
| Cell Movement | 2 | 2018 | 5212 | 0.320 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2012 | 1337 | 0.300 |
Why?
|
| Tetanus | 1 | 2024 | 53 | 0.240 |
Why?
|
| Prostatic Neoplasms | 2 | 2018 | 11039 | 0.220 |
Why?
|
| Cell Proliferation | 5 | 2018 | 10472 | 0.200 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 3557 | 0.190 |
Why?
|
| Phthalic Acids | 2 | 2018 | 436 | 0.190 |
Why?
|
| Dengue Virus | 1 | 2022 | 204 | 0.180 |
Why?
|
| Serologic Tests | 1 | 2022 | 374 | 0.180 |
Why?
|
| Down-Regulation | 2 | 2017 | 3001 | 0.180 |
Why?
|
| Tobacco, Smokeless | 2 | 2010 | 129 | 0.170 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11472 | 0.160 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7721 | 0.160 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 352 | 0.160 |
Why?
|
| Transfection | 2 | 2018 | 5892 | 0.150 |
Why?
|
| Textiles | 1 | 2017 | 46 | 0.150 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 553 | 0.150 |
Why?
|
| Immunoglobulin M | 1 | 2022 | 1538 | 0.150 |
Why?
|
| Phthalazines | 1 | 2019 | 361 | 0.140 |
Why?
|
| Environmental Exposure | 5 | 2018 | 4231 | 0.140 |
Why?
|
| Cell Cycle | 2 | 2017 | 2964 | 0.140 |
Why?
|
| Up-Regulation | 2 | 2018 | 4211 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 808 | 0.140 |
Why?
|
| Nicotine | 2 | 2010 | 677 | 0.130 |
Why?
|
| Phenols | 2 | 2009 | 501 | 0.130 |
Why?
|
| Gene Expression | 2 | 2018 | 7790 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2010 | 987 | 0.120 |
Why?
|
| Carboplatin | 1 | 2017 | 799 | 0.120 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2017 | 285 | 0.120 |
Why?
|
| Benzimidazoles | 1 | 2019 | 848 | 0.120 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 617 | 0.120 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3164 | 0.120 |
Why?
|
| Random Allocation | 1 | 2018 | 2425 | 0.120 |
Why?
|
| Signal Transduction | 4 | 2019 | 23387 | 0.120 |
Why?
|
| Nitriles | 1 | 2018 | 952 | 0.110 |
Why?
|
| Mice, SCID | 1 | 2018 | 2715 | 0.110 |
Why?
|
| Benzamides | 1 | 2018 | 1378 | 0.110 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 400 | 0.100 |
Why?
|
| HCT116 Cells | 1 | 2013 | 408 | 0.100 |
Why?
|
| Parabens | 2 | 2009 | 108 | 0.100 |
Why?
|
| Disease-Free Survival | 2 | 2019 | 6891 | 0.100 |
Why?
|
| Prostate | 1 | 2019 | 1764 | 0.100 |
Why?
|
| Nitrosamines | 1 | 2010 | 87 | 0.090 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2017 | 569 | 0.090 |
Why?
|
| Nutrition Surveys | 4 | 2024 | 1656 | 0.090 |
Why?
|
| Orchiectomy | 1 | 2012 | 466 | 0.090 |
Why?
|
| Mice | 4 | 2019 | 81045 | 0.090 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2013 | 414 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 3504 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1786 | 0.090 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2009 | 361 | 0.080 |
Why?
|
| Male | 12 | 2019 | 349538 | 0.080 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2008 | 54 | 0.080 |
Why?
|
| Piperazines | 1 | 2019 | 2488 | 0.080 |
Why?
|
| RNA Interference | 1 | 2017 | 2890 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6534 | 0.080 |
Why?
|
| Carcinogens | 1 | 2010 | 466 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1655 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2017 | 2500 | 0.080 |
Why?
|
| Histones | 1 | 2017 | 2597 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2723 | 0.070 |
Why?
|
| Humans | 21 | 2024 | 742088 | 0.070 |
Why?
|
| Fluorocarbons | 1 | 2011 | 452 | 0.070 |
Why?
|
| Carcinoma | 1 | 2017 | 2374 | 0.060 |
Why?
|
| Animals | 4 | 2019 | 168561 | 0.060 |
Why?
|
| Plasticizers | 2 | 2018 | 47 | 0.060 |
Why?
|
| Binding Sites | 1 | 2012 | 6115 | 0.060 |
Why?
|
| Tetanus Toxoid | 1 | 2024 | 193 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5851 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2018 | 13029 | 0.050 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2008 | 778 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2024 | 340 | 0.050 |
Why?
|
| Puerto Rico | 1 | 2022 | 356 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9410 | 0.050 |
Why?
|
| Health Surveys | 1 | 2011 | 4030 | 0.050 |
Why?
|
| Chromatin | 1 | 2012 | 2917 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 2522 | 0.050 |
Why?
|
| Neoplasms | 1 | 2009 | 21596 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 402 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2009 | 1180 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2022 | 841 | 0.040 |
Why?
|
| Benzophenones | 2 | 2009 | 57 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2008 | 2041 | 0.040 |
Why?
|
| Solid Phase Extraction | 1 | 2018 | 28 | 0.040 |
Why?
|
| Triclosan | 2 | 2009 | 55 | 0.040 |
Why?
|
| Dengue | 1 | 2022 | 256 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18006 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 2542 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2024 | 1469 | 0.040 |
Why?
|
| Laboratories | 1 | 2021 | 461 | 0.040 |
Why?
|
| Silanes | 1 | 2017 | 28 | 0.040 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2017 | 40 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 3639 | 0.040 |
Why?
|
| Viral Matrix Proteins | 1 | 2017 | 186 | 0.030 |
Why?
|
| Cell Line | 1 | 2009 | 15994 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 1574 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 3862 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 401 | 0.030 |
Why?
|
| Taxoids | 1 | 2017 | 665 | 0.030 |
Why?
|
| Environmental Monitoring | 2 | 2010 | 1413 | 0.030 |
Why?
|
| Benzhydryl Compounds | 2 | 2009 | 840 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 17400 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 29717 | 0.030 |
Why?
|
| Vaccination | 1 | 2024 | 3256 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2017 | 1040 | 0.030 |
Why?
|
| Sulfonic Acids | 1 | 2011 | 95 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2010 | 162 | 0.020 |
Why?
|
| Caprylates | 1 | 2011 | 111 | 0.020 |
Why?
|
| Genome, Human | 2 | 2017 | 4420 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12220 | 0.020 |
Why?
|
| Chlorophenols | 1 | 2009 | 16 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 15494 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 6754 | 0.020 |
Why?
|
| Drug Stability | 1 | 2009 | 290 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 3612 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 140 | 0.020 |
Why?
|
| Child | 4 | 2024 | 77478 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2009 | 154 | 0.020 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2008 | 81 | 0.020 |
Why?
|
| Linear Models | 1 | 2018 | 5948 | 0.020 |
Why?
|
| United States | 3 | 2024 | 69693 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2017 | 2458 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 14720 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2018 | 2933 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4839 | 0.020 |
Why?
|
| Equipment and Supplies | 1 | 2008 | 281 | 0.020 |
Why?
|
| Adult | 5 | 2024 | 213712 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 2552 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2008 | 676 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 2003 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 2900 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 10248 | 0.010 |
Why?
|
| Young Adult | 3 | 2018 | 56350 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 20774 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11001 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5163 | 0.010 |
Why?
|
| Aged | 3 | 2024 | 162944 | 0.010 |
Why?
|
| Adolescent | 3 | 2018 | 85649 | 0.010 |
Why?
|
| Middle Aged | 4 | 2018 | 213127 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2010 | 2572 | 0.010 |
Why?
|
| Alleles | 1 | 2009 | 6931 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 9387 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29010 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 40955 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 9581 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2017 | 40450 | 0.010 |
Why?
|
| Female | 4 | 2018 | 379592 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 72145 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 40054 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 77098 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 25575 | 0.010 |
Why?
|
Concepts
(165)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_